Citigroup
TNGX icon

Citigroup’s Tango Therapeutics TNGX Stock Holding History

Citigroup’s Portfolio TNGX Stock Details TNGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$411K Sell
19,633
-16,603
-46% -$231K ﹤0.01% 3660
2025
Q4 		$321K Buy
36,236
+18,134
+100% +$156K ﹤0.01% 3788
2025
Q3 		$152K Sell
18,102
-12,189
-40% -$82.5K ﹤0.01% 4104
2025
Q2 		$155K Sell
30,291
-11,532
-28% -$28.5K ﹤0.01% 4181
2025
Q1 		$57.3K Sell
41,823
-5,169
-11% -$12.7K ﹤0.01% 4845
2024
Q4 		$145K Buy
46,992
+8,316
+22% +$38.6K ﹤0.01% 4630
2024
Q3 		$298K Buy
38,676
+16,611
+75% +$159K ﹤0.01% 4080
2024
Q2 		$189K Sell
22,065
-169,368
-88% -$1.31M ﹤0.01% 3902
2024
Q1 		$1.52M Buy
191,433
+183,270
+2,245% +$1.96M ﹤0.01% 2672
2023
Q4 		$80.8K Buy
8,163
+6,945
+570% +$60.3K ﹤0.01% 4288
2023
Q3 		$13.7K Sell
1,218
-14,910
-92% -$90.9K ﹤0.01% 4480
2023
Q2 		$53.5K Buy
16,128
+7,937
+97% +$28.6K ﹤0.01% 4605
2023
Q1 		$32.4K Sell
8,191
-2,152
-21% -$12.5K ﹤0.01% 4372
2022
Q4 		$75K Sell
10,343
-1,449
-12% -$10.2K ﹤0.01% 4137
2022
Q3 		$43K Sell
11,792
-1,752
-13% -$7.48K ﹤0.01% 4457
2022
Q2 		$61K Sell
13,544
-23,165
-63% -$140K ﹤0.01% 4455
2022
Q1 		$278K Buy
36,709
+4,267
+13% +$37K ﹤0.01% 3887
2021
Q4 		$355K Buy
32,442
+29,273
+924% +$352K ﹤0.01% 4023
2021
Q3 		$41K Buy
+3,169
New +$38K ﹤0.01% 4844

Other funds holding TNGX

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $762M AUM 1,125.36% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
TGI
TRV GP IV Boston, Massachusetts $267M AUM 965.83% 1-Year Est. Return

Citigroup's TNGX Position: Q1 2026 in Review

Citigroup reduced its Tango Therapeutics (TNGX) stake by 46% in Q1 2026, selling an estimated $231K and leaving 19,633 shares worth $411K. The position accounts for ﹤0.01% of the portfolio, ranked #3660.

Citigroup first reported a position in TNGX in Q3 2021 and has held it in 19 quarters since. The position peaked at $1.52M in Q1 2024. 194 funds tracked by Wall St. Rank hold TNGX as of Q1 2026.

  • Citigroup held 19,633 shares of Tango Therapeutics worth $411K as of Q1 2026.
  • Citigroup sold 16,603 Tango Therapeutics shares in Q1 2026, an estimated $231K.
  • Tango Therapeutics made up ﹤0.01% of Citigroup's portfolio in Q1 2026, its #3660 holding.
  • Citigroup first reported a position in Tango Therapeutics in Q3 2021 and has held it in 19 quarters since.
  • Citigroup's Tango Therapeutics position peaked at $1.52M in Q1 2024.
  • 194 funds tracked by Wall St. Rank held Tango Therapeutics as of Q1 2026.

Based on Citigroup's 13F filing for Q1 2026, filed 11 May 2026.